Estimating the impact of influenza vaccination of low-risk 50–64-year-olds on acute and ICU hospital bed usage in an influenza season under endemic COVID-19 in the UK-Reference-Cited by-同舟云学术

Estimating the impact of influenza vaccination of low-risk 50–64-year-olds on acute and ICU hospital bed usage in an influenza season under endemic COVID-19 in the UK

Published:2023-01-02 Issue:1 Volume:19 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Nguyen Van Hung¹,Ashraf Mansoor²,Mould-Quevedo Joaquin F.³^ORCID

Affiliation:

1. VHN Consulting Inc, Montreal, Canada

2. Medical Affairs, Seqirus UK, Maidenhead, Berkshire, UK

3. Global Medical Affairs, Seqirus USA Inc, Summit, NJ, USA

Funder

funded by CSL Seqirus Inc

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2023.2187592

Reference28 articles.

1. World Health Organization. Influenza (Seasonal) fact sheet. 2018 [accessed 2023 Jan 10]. https://www.who.int/news-room/fact-sheets/detail/influenza-/seasonal/.

2. High-risk Groups for Influenza Complications

3. Vaccinating healthcare workers against influenza to protect the vulnerable—Is it a good use of healthcare resources?A systematic review of the evidence and an economic evaluation

4. Influenza

5. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modelling the population-level benefits and cost-effectiveness of cell-based quadrivalent influenza vaccine for children and adolescents aged 6 months to 17 years in the US;Expert Review of Vaccines;2023-12-14

2. Influenza vaccination uptake among at‐risk patients in Switzerland—The potential of national claims data for surveillance;Influenza and Other Respiratory Viruses;2023-10

3. The burden of influenza and the role of influenza vaccination in adults aged 50-64 years: A summary of available evidence;Human Vaccines & Immunotherapeutics;2023-08

4. Cost-Effectiveness of the Use of Adjuvanted Quadrivalent Seasonal Influenza Vaccine in Older Adults in Ireland;Vaccines;2023-05-03